65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award

Active Awarded Last action

Contract number
36F79722D0135
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 86% complete
IDV ceiling
$64,557,260.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

Veloxis Pharmaceuticals, Inc. (Unique Entity Identifier: YJQMS7XCLTM7) has been awarded a multiple-award Federal Supply Schedule contract under the Pharmaceuticals and Drugs program (FSS-61-IB) to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), a civilian agency component of the Department of Veterans Affairs. The contract was awarded on July 1, 2022, with an ultimate completion date of June 30, 2027, establishing a five-year period of performance. No set-aside provisions were applied to this award, allowing competition across all eligible vendors. The contract carries a ceiling value of $64,557,260.00 and operates as an indefinite delivery vehicle, enabling the Department of Veterans Affairs to issue task orders against the established terms and conditions as pharmaceutical supply needs arise.

Under this Federal Supply Schedule contract, Veloxis Pharmaceuticals will supply pharmaceutical products and related hematology items to support the clinical and operational requirements of VISN 12's healthcare facilities and programs. As a multiple-award contract vehicle, this arrangement allows the Veterans Integrated Service Network to leverage competitive pricing and established vendor relationships while maintaining procurement flexibility through task order issuance. The contract structure enables efficient procurement of essential pharmaceutical inventories required to support veteran healthcare delivery across the network's constituent medical centers and clinics throughout the contract period.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · 2026 public law $0
Other Administrative Action P00009 · 65IB administrative change - sales POC $0
Supplemental Agreement for work within scope P00008 · Incorporation of 2025 subk plan $0
Supplemental Agreement for work within scope P00007 · 65IB 2025 public law pricing updates $0
Other Administrative Action P00006 · 65IB administrative changes $0
Supplemental Agreement for work within scope P00005 · Incorporation of 2024 small business subcontracting plan $0
Supplemental Agreement for work within scope P00004 · 2024 PL updates. $0
Supplemental Agreement for work within scope P00003 · Incorporation of 2023 small business subcontracting plan $0
Other Administrative Action P00002 · 65IB admin point of contact change $0
Supplemental Agreement for work within scope P00001 · 2023 public law pricing updates $0
Original award $0
Show all 11

Quick answers

Who was awarded contract 36F79722D0135?

36F79722D0135 was awarded to Veloxis Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 1, 2022.

How much is contract 36F79722D0135 worth?

36F79722D0135's own ceiling is $64,557,260.

Who can order from contract 36F79722D0135?

36F79722D0135 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79722D0135 part of a contract vehicle?

Yes. 36F79722D0135 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79722D0135 competed?

The extent of competition for 36F79722D0135 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV